INS and neoplasm: Its indirect effects are likely to be due to inhibition of hepatic gluconeogenesis, resulting in an improvement in insulin sensitivity and a reduction of blood glucose and circulating insulin levels, which may lead to decreased growth factor-stimulated tumor growth 7,8.